Valuation: Granules India Limited

Market Cap 218B 2.26B 1.98B 1.83B 1.68B 3.17B 3.24B 21.83B 8.59B 107B 8.5B 8.32B 368B P/E 2026
25.4x
P/E 2027 * 28.6x
Enterprise Value 221B 2.29B 2B 1.85B 1.7B 3.21B 3.28B 22.09B 8.69B 108B 8.61B 8.42B 372B EV / Sales 2026
2.94x
EV / Sales 2027 * 3.54x
Free-Float
60.69%
Yield 2026
0.28%
Yield 2027 * 0.16%
1 day-2.55%
1 week-0.12%
Current month+8.25%
1 month+17.52%
3 months+35.23%
6 months+51.32%
Current year+47.04%
1 week 870.7
Extreme 870.7
910
1 month 741.4
Extreme 741.4
910
Current year 520.05
Extreme 520.05
910
1 year 433
Extreme 433
910
3 years 287.55
Extreme 287.55
910
5 years 227
Extreme 227
910
10 years 71.75
Extreme 71.75
910
Manager TitleAgeSince
Chief Executive Officer 71 31/07/2025
President - 14/10/2024
President - 01/09/2023
Director TitleAgeSince
Chairman 71 21/08/2013
Director/Board Member 42 01/01/2005
Director/Board Member 66 31/05/2012
Change 5-day change 1-year change 3-year change Capi.($)
-2.55%-0.12%+76.16%+185.14% 2.32B
+0.57%-1.22%+54.19%+162.59% 1,043B
+1.06%-1.92%+54.65%+58.46% 602B
+0.46%+3.13%+33.67%+89.75% 449B
+0.78%-0.71%+30.04%+24.61% 327B
+1.41%+0.58%+33.92%+47.20% 279B
-0.27%-1.87%+22.13%+23.47% 264B
-2.28%+0.03%+21.87%+59.54% 201B
-1.14%+3.77%+23.82%+73.88% 169B
-0.42%+3.70%+1.97%-30.10% 143B
Average -0.28%-0.37%+35.24%+69.45% 347.94B
Weighted average by Cap. +0.34%-1.81%+39.81%+84.21%

Financials

2026 2027 *
Net sales 53.08B 551M 482M 445M 410M 772M 789M 5.31B 2.09B 26B 2.07B 2.02B 89.5B 62.13B 645M 564M 520M 480M 904M 924M 6.22B 2.45B 30.43B 2.42B 2.37B 105B
Net income 5.89B 61.21M 53.49M 49.36M 45.5M 85.75M 87.66M 590M 232M 2.89B 230M 225M 9.94B 7.76B 80.57M 70.41M 64.97M 59.89M 113M 115M 777M 305M 3.8B 303M 296M 13.08B
Net Debt 2.64B 27.43M 23.98M 22.12M 20.39M 38.44M 39.29M 264M 104M 1.29B 103M 101M 4.45B 1.87B 19.41M 16.97M 15.65M 14.43M 27.2M 27.8M 187M 73.6M 916M 72.91M 71.31M 3.15B
Logo Granules India Limited
Granules India Limited is an India-based pharmaceutical manufacturing company. The Company operates through its pharmaceutical products segment. Its geographical segments include within India and outside India. The Company has a presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). It produces and supplies Paracetamol, Metformin, Guaifenesin, and Methocarbamol APIs. It has over 10 manufacturing facilities, approximately eight of which are located in India and two in the United States. The Company sells its products in global markets, including the United States of America, Canada, Latin America, Europe, Asia Pacific, and India. Its subsidiaries include Granules USA Inc and Granules Europe Limited. It also owns Senn Chemicals AG, a contract development and manufacturing organization (CDMO) specializing in peptide development and manufacturing.
Employees
4,066
Date Price Change Volume
17/07/26 880.10 -2.55% 19,674
16/07/26 ₹903.15 +0.58% 20,358
15/07/26 ₹897.90 +0.33% 37,515
14/07/26 ₹894.95 -0.28% 23,773
13/07/26 ₹897.50 +0.89% 22,609
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
880.10INR
Average target price
802.29INR
Spread / Average Target
-8.84%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GRANULES Stock